Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa (MENA) region. Its GM, Zeina Sfeir Lahoud, discusses the company’s presence in over 17 countries, their 25 years of experience in Saudi Arabia, and the dynamics shaping the largest market in the region, including the fast regulatory approval process in place. With value-based healthcare an increasingly hot topic, she explains how Biologix has moved to sign the first risk-sharing agreement with Saudi Arabia for a spinal muscular atrophy product; the first in the MENA region.
STAY UP TO DATE NEWS & EVENTS
Related EVENTS & NEWS
Biologix sponsored the Formulary Management Conference
Biologix sponsored the Formulary Management Conference held in JW Marriott Riyadh KSA on 9th and 10th of May 2023.
Biologix takes the lead at the Hematology Oncology Pharmacy summit (HOPS)
Biologix as a silver sponsor at the 4th Allergy & Clinical Immunology Conference
